DGX vs. LH
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Laboratory Corporation of America Holdings (LH).
Performance
DGX vs. LH - Performance Comparison
Loading graphics...
DGX vs. LH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 14.44% | 17.20% | 11.77% | -10.05% | -7.80% | 47.86% | 14.11% | 31.13% | -13.84% | 9.16% |
LH Laboratory Corporation of America Holdings | 8.99% | 10.62% | 2.22% | 13.82% | -24.41% | 54.37% | 20.32% | 33.88% | -20.78% | 24.25% |
Fundamentals
DGX:
$22.14B
LH:
$22.69B
DGX:
$8.80
LH:
$10.48
DGX:
22.45
LH:
26.03
DGX:
2.02
LH:
1.64
DGX:
3.09
LH:
2.63
DGX:
$11.04B
LH:
$13.95B
DGX:
$3.67B
LH:
$4.01B
DGX:
$2.02B
LH:
$1.86B
Returns By Period
In the year-to-date period, DGX achieves a 14.44% return, which is significantly higher than LH's 8.99% return. Over the past 10 years, DGX has outperformed LH with an annualized return of 12.77%, while LH has yielded a comparatively lower 10.90% annualized return.
DGX
- 1D
- 0.87%
- 1M
- -5.97%
- YTD
- 14.44%
- 6M
- 9.56%
- 1Y
- 18.95%
- 3Y*
- 14.07%
- 5Y*
- 11.00%
- 10Y*
- 12.77%
LH
- 1D
- 2.22%
- 1M
- -4.79%
- YTD
- 8.99%
- 6M
- -1.76%
- 1Y
- 18.49%
- 3Y*
- 12.81%
- 5Y*
- 5.68%
- 10Y*
- 10.90%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DGX vs. LH — Risk / Return Rank
DGX
LH
DGX vs. LH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Laboratory Corporation of America Holdings (LH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DGX | LH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.81 | 0.73 | +0.08 |
Sortino ratioReturn per unit of downside risk | 1.38 | 1.18 | +0.21 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.15 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.94 | 1.21 | +0.73 |
Martin ratioReturn relative to average drawdown | 4.31 | 2.91 | +1.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| DGX | LH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.81 | 0.73 | +0.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.25 | +0.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | 0.41 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.18 | +0.35 |
Correlation
The correlation between DGX and LH is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
DGX vs. LH - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.62%, more than LH's 1.06% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.62% | 1.82% | 1.96% | 2.02% | 1.66% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% |
LH Laboratory Corporation of America Holdings | 1.06% | 1.15% | 1.26% | 1.18% | 0.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
DGX vs. LH - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum LH drawdown of -96.15%. Use the drawdown chart below to compare losses from any high point for DGX and LH.
Loading graphics...
Drawdown Indicators
| DGX | LH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.46% | -96.15% | +46.69% |
Max Drawdown (1Y)Largest decline over 1 year | -9.81% | -15.22% | +5.41% |
Max Drawdown (5Y)Largest decline over 5 years | -28.62% | -34.61% | +5.99% |
Max Drawdown (10Y)Largest decline over 10 years | -36.60% | -46.58% | +9.98% |
Current DrawdownCurrent decline from peak | -6.71% | -5.77% | -0.94% |
Average DrawdownAverage peak-to-trough decline | -11.92% | -29.71% | +17.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 6.33% | -1.92% |
Volatility
DGX vs. LH - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 4.48%, while Laboratory Corporation of America Holdings (LH) has a volatility of 6.44%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than LH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| DGX | LH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.48% | 6.44% | -1.96% |
Volatility (6M)Calculated over the trailing 6-month period | 16.61% | 17.23% | -0.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.52% | 25.36% | -1.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.65% | 23.23% | -1.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.63% | 26.53% | -2.90% |
Financials
DGX vs. LH - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DGX vs. LH - Profitability Comparison
DGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported a gross profit of 910.00M and revenue of 2.81B. Therefore, the gross margin over that period was 32.4%.
LH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported a gross profit of 993.20M and revenue of 3.52B. Therefore, the gross margin over that period was 28.3%.
DGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported an operating income of 386.00M and revenue of 2.81B, resulting in an operating margin of 13.8%.
LH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported an operating income of 267.60M and revenue of 3.52B, resulting in an operating margin of 7.6%.
DGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported a net income of 245.00M and revenue of 2.81B, resulting in a net margin of 8.7%.
LH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported a net income of 164.70M and revenue of 3.52B, resulting in a net margin of 4.7%.